Editas Medicine, Inc. (EDIT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:54PM EDT. Market open.
| Previous close | 5.67 |
| Open | 5.73 |
| Bid | 5.61 x 200 |
| Ask | 5.64 x 200 |
| Day's range | 5.55 - 5.78 |
| 52-week range | 5.11 - 11.91 |
| Volume | |
| Avg. volume | 1,962,475 |
| Market cap | 462.981M |
| Beta (5Y monthly) | 2.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Editas Medicine, Inc. (NASDAQ:EDIT) is a favorite amongst institutional investors who own 71%
Key Insights Significantly high institutional ownership implies Editas Medicine's stock price is sensitive to their...
- Insider Monkey
12 Under-the-Radar Stocks With Massive Upside for 2024
In this piece, we will take a look at the 12 under the radar stocks with massive upside for 2024. If you want to skip our overview of shareholder ownership and how shares can jump if they come ‘over’ the radar instead of under, then you can jump ahead to 5 Under-the-Radar Stocks With Massive […]
- Zacks
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Editas (EDIT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.